Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-87.08	3.43	26.57
Graham Fair Price	82.92	52.10	28.48
PEG	-94.61	0.02	-0.30
Price/Book	-2.28	1.11	1.13
Price/Cash Flow	10.71	7.52	6.79
Prices/Earnings	-63.45	3.27	8.94
Price/Sales	-34.07	2.83	4.30
Price/FCF	10.71	7.52	6.79
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.66	0.84	0.74
Operating Margin	332.86	0.64	0.15
ROA	184.91	0.01	< 0.005
ROE	0.03	0.08	167.35
ROIC	0.01	0.08	550.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.05	-80.84
Dividends QOQ	< 0.005	< 0.005	-10.96
EBIT QOQ	-0.35	6.05	1614.72
EPS QOQ	-0.30	2.05	578.14
FCF QOQ	-0.07	-0.03	55.20
Revenue QOQ	-0.32	0.63	98.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-7365.68	-6679.91	9.31
Days Sales Outstanding (DSO)	2273.17	1371.33	-39.67
Inventory Turnover	-0.01	-0.01	-10.27
Debt/Capitalization	0.59	0.55	-6.43
Quick Ratio	25.96	25.88	-0.31
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.75	37.76	11.87
Cash	43.84	56.90	29.78
Capex	0.00	0.00	0.00
Free Cash Flow	5.63	5.55	-1.25
Revenue	8.88	14.73	65.81
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.35	4.55	35.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.62	-1.03	-60.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating